or Try an Advanced Search...

    Gilead Sciences Stocks List

    Symbol Grade Name % Change
    NRIX B Nurix Therapeutics, Inc. -9.26
    HOOK D HOOKIPA Pharma Inc. -4.92
    GILD D Gilead Sciences, Inc. 3.62
    HEPA F Hepion Pharmaceuticals, Inc. -6.81
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Biotechnology Cancer Hepatitis B Hepatotoxins Immunodeficiency Life Sciences Liver Disease Medicine Tenofovir Disoproxil Angina Antibiotics Bruton's Tyrosine Kinase Cardiovascular Disease Chronic Liver Disease Chronic Liver Diseases Coronavirus Cyclophilin Cystic Fibrosis Cytomegalovirus Retinitis

    Related ETFs - A few ETFs which own one or more of the above listed Gilead Sciences stocks.

    Symbol Grade Name Weight
    BIS D ProShares UltraShort Nasdaq Biotechnology 7.41
    IBBQ A Invesco Nasdaq Biotechnology ETF 7.34
    IBB B iShares Nasdaq Biotechnology Index Fund 7.21
    BBH B Market Vectors Biotech ETF 7.01
    HDLB C ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 5.14
    View all Gilead Sciences ETFs...
    Compare ETFs
    Compare BIS to HDLB Compare IBBQ to BBH Compare IBBQ to IBB

        Gilead Sciences Stocks Recent News

        Date Stock Title
        Jun 14 GILD Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
        Jun 14 GILD EU to require additional cancer risk labeling on CAR T therapies
        Jun 14 GILD Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.
        Jun 14 GILD Gilead spikes as Jefferies highlights weight loss prospects
        Jun 14 GILD New Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of Treatment
        Jun 13 GILD Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
        Jun 13 GILD Gilead Sciences, Inc. (GILD) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
        Jun 12 GILD How Luciana Preger Is Helping Advance Gilead’s Work in Oncology
        Jun 12 NRIX Nurix Therapeutics files for mixed shelf securities offering
        Jun 10 NRIX Nurix Therapeutics to Host a Webcast and Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of NX-5948 Being Presented at the European Hematology Association Congress (EHA2024)
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Biotechnology Cancer Hepatitis B Hepatotoxins Immunodeficiency Life Sciences Liver Disease Medicine Tenofovir Disoproxil Angina Antibiotics Bruton's Tyrosine Kinase Cardiovascular Disease Chronic Liver Disease Chronic Liver Diseases Coronavirus Cyclophilin Cystic Fibrosis Cytomegalovirus Retinitis
        Gilead Sciences

        Gilead Sciences, Inc. , is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
        Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

        More about Gilead Sciences
        Browse All Tags